fenfluramine and bosentan anhydrous

fenfluramine has been researched along with bosentan anhydrous in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Widmar, B	1
Humbert, M; Jardim, C; Souza, R	1

Reviews

1 review(s) available for fenfluramine and bosentan anhydrous

Article	Year
When cure is care: diagnosis and management of pulmonary arterial hypertension. Journal of the American Academy of Nurse Practitioners, 2005, Volume: 17, Issue:3 Topics: Adenosine; Algorithms; Antihypertensive Agents; Bosentan; Bronchodilator Agents; Calcium Channel Blockers; Decision Trees; Diagnosis, Differential; Epoprostenol; Fatal Outcome; Fenfluramine; Health Promotion; Humans; Hypertension, Pulmonary; Iloprost; Lung Transplantation; Nitric Oxide; Nurse Practitioners; Primary Health Care; Prognosis; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sulfonamides; Vasodilator Agents	2005

Article

Year

When cure is care: diagnosis and management of pulmonary arterial hypertension.

Journal of the American Academy of Nurse Practitioners, 2005, Volume: 17, Issue:3

Topics: Adenosine; Algorithms; Antihypertensive Agents; Bosentan; Bronchodilator Agents; Calcium Channel Blockers; Decision Trees; Diagnosis, Differential; Epoprostenol; Fatal Outcome; Fenfluramine; Health Promotion; Humans; Hypertension, Pulmonary; Iloprost; Lung Transplantation; Nitric Oxide; Nurse Practitioners; Primary Health Care; Prognosis; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sulfonamides; Vasodilator Agents

2005

Other Studies

1 other study(ies) available for fenfluramine and bosentan anhydrous

Article	Year
Idiopathic pulmonary arterial hypertension. Seminars in respiratory and critical care medicine, 2013, Volume: 34, Issue:5 Topics: Aminorex; Antihypertensive Agents; Appetite Depressants; Bosentan; Dasatinib; Epoprostenol; Familial Primary Pulmonary Hypertension; Fenfluramine; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Iloprost; Phenylpropionates; Piperazines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyridazines; Pyrimidines; Risk Factors; Sildenafil Citrate; Sulfonamides; Sulfones; Thiazoles; Vasodilator Agents	2013

Article

Year

Idiopathic pulmonary arterial hypertension.

Seminars in respiratory and critical care medicine, 2013, Volume: 34, Issue:5

Topics: Aminorex; Antihypertensive Agents; Appetite Depressants; Bosentan; Dasatinib; Epoprostenol; Familial Primary Pulmonary Hypertension; Fenfluramine; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Iloprost; Phenylpropionates; Piperazines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyridazines; Pyrimidines; Risk Factors; Sildenafil Citrate; Sulfonamides; Sulfones; Thiazoles; Vasodilator Agents

2013